Se espera que el mercado de la biología sintética crezca de 10.544,16 millones de dólares en 2021 a 37.850,85 millones de dólares en 2028; se estima que crecerá a una tasa compuesta anual del 20,0% de 2021 a 2028.
La biología sintética médica es la ciencia de diseñar, alterar y construir organismos simples para realizar utilidades terapéuticas o industriales específicas. Los organismos creados son organismos genéticamente modificados (OGM), que no requieren una definición que los distinga de las modificaciones genéticas. El crecimiento del mercado de la biología sintética se atribuye al aumento de las inversiones, los avances tecnológicos y el creciente número de empresas de nueva creación. Además, es probable que las tendencias emergentes en biología sintética tengan un impacto positivo en el crecimiento del mercado en los próximos años.
Perspectivas estratégicas
El mercado de la biología sintética está segmentado en producto, tecnología y aplicación. y geografía. Por geografía, el mercado está ampliamente segmentado en América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y el Sur y el Sur. Centroamérica. El informe de mercado de biología sintética ofrece información y un análisis en profundidad del mercado, enfatizando las tendencias del mercado, los avances tecnológicos, la dinámica del mercado y el análisis competitivo de los principales actores del mercado a nivel mundial.
regiones lucrativas para la biología sintética Mercado de la biología
Perspectivas del mercado
La creciente inversión en biología sintética impulsa el mercado de la biología sintética
La biología sintética es un concepto emergente que tiene numerosas aplicaciones en los sectores químico, agrícola, farmacéutico y energético. industrias. Varias empresas emergentes ofrecen productos/servicios de síntesis de genes para procesos biológicos. Por ejemplo, Benchling proporciona herramientas CAD, GenScript ofrece síntesis de genes, Ginkgo Bioworks ayuda en la ingeniería de organismos, Transcripts (una empresa de bioinformática) ofrece soluciones que facilitan la automatización y los laboratorios en la nube y Glowee ofrece productos de consumo. Además, 56 empresas de biología sintética recaudaron más de 3.000 millones de dólares en financiación de capital en el primer semestre de 2020, en comparación con 65 empresas que recaudaron 1.900 millones de dólares durante el mismo período de 2020. La nueva generación de empresas biofarmacéuticas utiliza la biología sintética para mejorar tratamiento celular y terapia génica y apoyo a la detección temprana del cáncer. A continuación se enumeran algunas empresas de biología sintética con mayor financiación en el primer semestre de 2020:
Empresas de biología sintética con mayor financiación en el primer semestre de 2020
< h3>Product InsightsSegún el producto, el mercado mundial de biología sintética se segmenta en oligonucleótidos, organismos chasis, enzimas y ácido xenonucleico. El segmento de oligonucleótidos tuvo la mayor participación del mercado en 2021. Además, se prevé que el mismo segmento registre la CAGR más alta del mercado durante el período previsto de 2021 a 2028. Esto se debe principalmente a la creciente aplicación de oligonucleótidos en pruebas genéticas. / ensayos y ciencias forenses.
Mercado de biología sintética, por producto (2021-2028)
Perspectivas tecnológicas< /h3>
Basado en la tecnología, el mercado mundial de la biología sintética se segmenta en síntesis de genes, ingeniería genómica, medición y análisis. modelado, clonación y secuenciación, nanotecnología y otros. En 2021, es probable que el segmento de síntesis de genes tenga la mayor participación del mercado. Sin embargo, se espera que el segmento de ingeniería genómica registre la CAGR más alta de 2021 a 2028. El crecimiento del segmento de ingeniería genómica se debe a las crecientes aplicaciones de la ingeniería genética y la terapia génica.
Application Insights
Basado en la aplicación, el mercado global de biología sintética se segmenta en aplicaciones médicas, aplicaciones industriales, aplicaciones ambientales, alimentación y agricultura, y otras. El segmento de aplicaciones médicas se segmenta aún más en descubrimiento y aplicación de fármacos. terapéutica y farmacéutica. En 2021, el segmento de aplicaciones médicas tuvo la mayor participación de mercado y se espera que registre la CAGR más alta durante 2021-2028.
Los lanzamientos de productos y las colaboraciones son estrategias muy adoptadas por los actores del mercado global de biología sintética. A continuación se enumeran algunos de los desarrollos clave recientes del mercado:
- En febrero de 2022, Thermo Fisher Scientific anunció el lanzamiento del software GeneMapper, un paquete de software de genotipado flexible que proporciona mediciones de alelos de calidad y tamaño del ADN para todo genotipado basado en electroforesis de Thermo Fisher Scientific.
- En enero de 2022, Thermo Fisher Scientific anunció el lanzamiento del ensayo Oncomine BRCA GX. Es un ensayo de secuenciación dirigida de próxima generación (NGS) diseñado para proporcionar una amplificación integral de todas las regiones codificantes de los genes humanos BRCA1 y BRCA2, lo que permite una detección precisa y sensible de varias clases de mutaciones.
- En abril de 2022, Merck KGaA Adquisición de la plataforma MAST de Lonza, un sistema líder de muestreo de biorreactores automatizados. La adquisición de la plataforma MAST es otro hito para acelerar la innovación en la unidad de negocios de Soluciones de Procesos de Merck.
- En febrero de 2022, Merck anunció el cierre de la transacción para adquirir Exalead, luego de las autorizaciones regulatorias y el cumplimiento de otros requisitos habituales. condiciones de cierre, por aproximadamente US$ 780 millones en efectivo.
La pandemia de COVID-19 obligó a muchas empresas del mercado mundial de biología sintética a suspender sus operaciones comerciales por un corto plazo para seguir las nuevas regulaciones gubernamentales. para controlar la propagación de la enfermedad. Esta parada de las operaciones afectó directamente al flujo de ingresos del mercado mundial de la biología sintética. Además, se cesó la fabricación de productos industriales debido a la falta de materias primas y de mano de obra durante el período de confinamiento. Además, no se recibieron nuevos envíos por parte de empresas que operan en este sector. Por lo tanto, la paralización de las actividades industriales y el bloqueo de varios meses afectaron a la industria mundial de la biología sintética. El brote de COVID-19 afectó el crecimiento de la industria de la biología sintética debido a las medidas de bloqueo en los países y el retraso en la fabricación y producción de materias primas, materiales de proceso y productos intermedios utilizados en empresas farmacéuticas y biotecnológicas. Se prevé que el mercado sea testigo de una lenta recuperación durante el período de pronóstico.
Biología sintética – ndash; Segmentación del mercado
El mercado global de biología sintética está segmentado según el producto, la aplicación de tecnología y la geografía. Según el producto, el mercado se segmenta en oligonucleótidos, organismos chasis, enzimas y ácido xenonucleico. Basado en la tecnología, el mercado de la biología sintética se segmenta en síntesis de genes, ingeniería del genoma, medición y análisis. modelado, clonación y secuenciación, nanotecnología y otros. Según la aplicación, el mercado de la biología sintética se segmenta en aplicaciones médicas, aplicaciones industriales, aplicaciones ambientales, alimentación y agricultura, y otras. Por geografía, el mercado de la biología sintética está segmentado en América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y el Sur y el Sur. Centroamérica.
Perfiles de empresas
- THERMO FISHER SCIENTIFIC INC.
- Agilent Technologies, Inc.
- MERCK KGaA
- New England Biolabs
- Tecnologías de ADN integradas
- Twist Bioscience
- GenScript Biotech Corporation
- Novozymes A/S
- Codexis
- Amyris Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
As per application, the medical applications segment is accounted to grow at the fastest CAGR in the market during the forecast period.
The synthetic biology market majorly consists of the players such as Thermo Fisher Scientific
Agilent technologies; Merck KGaA; New England Biolabs; Integrated DNA Technologies; Twists Bioscience; Genscript Biotech corporation; Novozymes A/S; Codexis; Amyris among others.
The oligonucleotides segment held the largest revenue share in 2021.
Synthetic biology is a science of designing, altering and building simple organisms to perform specific therapeutic or industrial utilities. The commercialization or industrialization of biology renders processes quicker, cheaper and reliable. The organisms created are known as genetically modified organisms (GMOs), which do not require a definition that distinguishes it from genetic modifications.
The List of Companies - Synthetic Biology Market
- Thermo Fisher Scientific
- Agilent technologies
- Merck KGaA
- New England Biolabs
- Integrated DNA Technologies
- Twists Bioscience
- Genscript Biotech corporation
- Novozymes A/S
- Codexis
- Amyris
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2022
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2022
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2022
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2022
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2022
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2022
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2022
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)